Peter E Cannava, MD in Soldotna, AK - Ophthalmology

Peter E Cannava, MD is a Ophthalmology physician based in Soldotna, Alaska. Peter E Cannava is licensed to practice in Alaska (license number MD1040) and his current practice location is 161 N Binkley St, Ste 101, Soldotna, Alaska. He can be reached at his office (for appointments etc.) via phone at (907) 262-4462.

NPI number for Peter E Cannava is 1275545766 and his current mailing address is 161 N Binkley St, Ste 101, Soldotna, Alaska. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1275545766.

Contact Information

	Peter E Cannava, MD
	161 N Binkley St, Ste 101, Soldotna, AK 99669
	(907) 262-4462
	(907) 262-3914

Physician's Profile

Full Name	Peter E Cannava
Gender	Male
Speciality	Ophthalmology
Location	161 N Binkley St, Soldotna, Alaska
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1275545766
Provider Enumeration Date: 08/12/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Peter E Cannava such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1275545766	NPI	-	NPPES
MD1040	Medicaid	AK

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	MD1040 (Alaska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Peter E Cannava is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Peter E Cannava, MD 161 N Binkley St, Ste 101, Soldotna, AK 99669 Ph: (907) 262-4462	Peter E Cannava, MD 161 N Binkley St, Ste 101, Soldotna, AK 99669 Ph: (907) 262-4462

News Archive

Personal usage and patient recommendations for dietary supplements are quite common across specialties

For physicians within several medical specialties, including dermatology, cardiology and orthopedics, personal usage of and patient recommendations for dietary supplements are quite common-, according to a study published in Nutrition Journal, a peer-reviewed, on-line journal that focuses on the field of human nutrition.

Platelet receptor could help with diseases that impact RBCs

A receptor found on blood platelets whose importance as a potential pharmaceutical target has long been questioned may in fact be fruitful in drug testing, according to new research from Michigan State University chemists.

Emerald, FORMA sign strategic partnership for structure-based design of cancer drug candidates

Emerald BioStructures, a leading provider of integrated structural biology services, and FORMA Therapeutics, a drug discovery company, today announced the signing of a strategic partnership for the structure-based design of cancer drug candidates for FORMA's pipeline.

Quality diabetes care comes at a price

Researchers say that the Quality and Outcomes Framework that was introduced to UK general practice in 2004 may not be worth the expense of implementing in terms of benefiting patients.

Researchers to assess any cancer risk associated with low-dose radiation exposure from medical imaging tests

Researchers at the National Institutes of Health (NIH) Clinical Center are incorporating radiation dose exposure reports into the electronic medical record, an effort that they hope will lead to an accurate assessment of whether any cancer risk is associated with low-dose radiation exposure from medical imaging tests, according to an article in the February issue of the Journal of the American College of Radiology (JACR).

Peter E Cannava, MD - Ophthalmology in Soldotna, AK